Aymptomatic CMV viremia is associated with increased levels of serum amyloid A in patients with advanced HIV-infection.

  • Christoph Steininger
  • W Graninger
  • Alexander Zoufaly
  • B Zöllner
  • Heinz Hubert Feucht
  • M Kundi
  • I Stahmer
  • H-J Stellbrink
  • Jan van Lunzen

Abstract

OBJECTIVE: We evaluated assays for the measurement of acute phase protein levels in plasma for their usefulness to identify sensitively an inflammatory response to active cytomegalovirus CMV infection in HIV-infected patients. METHODS: Plasma samples were collected from 28 CMV-seropositive patients with advanced HIV-infection (CD4-cell count 3 mg/L discriminated with 100% sensitivity and 40% specificity between HIV-infected patients with and without active CMV infection. Sensitivity of fibronectin was 100% and specificity 15% at a threshold-value corresponding with the lower limit of normal values as defined by the manufacturer of the assay (>29 mg/dL). Levels of the other acute phase proteins evaluated did not correlate with detection of CMV-DNA in plasma. CONCLUSION: Increased levels of SAA indicate sensitively an inflammatory response to active CMV infection. Use of a CMV-specific virological assay is required to confirm the specificity of a high SAA-level but may be limited to samples with high SAA-levels. Hence, screening for increased levels of SAA in patients with advanced HIV-infection may allow early identification of active CMV infection.

Bibliographical data

Original languageGerman
Article number6
ISSN0949-2321
Publication statusPublished - 2008
pubmed 18558558